Company Filing History:
2 out of 270 
1 out of 242 
Years Active: 2015-2021
Title: The Innovative Mind of Stefan Irion: Transforming Genetic Research
Introduction
Stefan Irion, an accomplished inventor based in Toronto, Canada, has significantly contributed to the field of genetic research with his innovative approach to gene targeting. With three patents to his name, he has focused his work on improving genetic manipulation techniques, particularly concerning the human Rosa26 gene.
Latest Patents
Stefan Irion's most recent patents reflect his groundbreaking work in genetic engineering. One of his notable inventions involves a vector for targeting the human Rosa26 gene. This patent details a method for generating a transgenic eukaryotic cell population with a modified human Rosa26 locus. It includes the introduction of a functional DNA sequence into the human Rosa26 locus of starting eukaryotic cells. Additionally, the invention encompasses targeting vectors useful in this method, along with a cell population and a transgenic non-human animal featuring a modified human Rosa26 locus. Furthermore, it provides an isolated DNA sequence corresponding to the human Rosa26 locus.
Another significant patent by Irion centers on stem cell gene targeting, paralleling the previous invention. It again details a method for generating transgenic eukaryotic cell populations with modifications to the human Rosa26 locus, further demonstrating his expertise in this specialized area of research.
Career Highlights
Throughout his career, Stefan Irion has made substantial impacts in scientific research through his roles at prestigious institutions. He has worked at the Icahn School of Medicine at Mount Sinai and the Mount Sinai School of Medicine, contributing to advanced projects in genetics and cellular biology.
Collaborations
Irion has collaborated with several noteworthy professionals in the field, including esteemed coworkers such as Gordon Keller and Herve Luche. These collaborations highlight not only his expertise but also his ability to work effectively within research teams to drive innovation in genetic research.
Conclusion
Stefan Irion's work has paved the way for advancements in genetic modification and cell targeting. His innovative patents reflect a deep understanding of the complexities of genetic engineering, specifically within the context of human biology. As he continues his research, his contributions are expected to have a lasting impact on the field, potentially leading to significant breakthroughs in medical science and therapy.